Abstract
MDL 100,907 is a potent and selective antagonist of 5-HT(2A) serotonin receptors. Animal studies suggest that MDL 100,907 may behave as an atypical antipsychotic drug. Positron emission tomography (PET) using [11C]NMSP as the radiotracer was used to define the time course of 5-HT2 receptor occupancy in the human frontal cerebral cortex after a single oral dose of MDL 100,907 (10 or 20 mg) in nine healthy subjects. After the baseline scan each subject was studied three times post dosing at various time points. 5-HT2 occupancies were in the range of 70 and 90% after each dose. While the occupancy remains in this range over 24 hours after 20 mg MDL 100,907, it decreases by about 20% at 24 hours compared to the timepoint at 8 hours, when only 10 mg are administered (p < 0.05). Our results should allow determination of the appropriate dosing regimen for future trials in schizophrenic patients.
Original language | English (US) |
---|---|
Pages (from-to) | 175-185 |
Number of pages | 11 |
Journal | Neuropsychopharmacology |
Volume | 17 |
Issue number | 3 |
DOIs | |
State | Published - Sep 1997 |
Keywords
- 5-HT receptors
- Antipsychotic drugs
- Human
- MDL 100,907
- Positron emission tomography
ASJC Scopus subject areas
- Pharmacology
- Psychiatry and Mental health